The way government handled this is questionable in my POV.
Firstly, they were keen to get the DFS out within promised Nov - another delay + larger CAPEX to what was expected would have absolutley destroyed the SP.
However, they didn't build any hype and no TH is bit suss - gives me the impression that they rushed this out the door to meet the promised timeline.
The CAPEX - albeit high, this was expected, although as they've mentioned in DFS that they're working with the vendors to get the cost lower, it would have been great to see this reflected in DFS.
The delayed schedule - I mentioned on HC few weeks back about the delayed schedule. Few on here gave me sh*t for it, but whatever, it was expected.
From here, I feel there will be few months of SP pain. I hope the management deals better with FID and lives up to the 'world class management' as the people's expectations, and I pray to god that they have some finance magic hidden up the sleeves.
- Forums
- ASX - By Stock
- QPM
- Ann: TECH Project Feasibility Study
Ann: TECH Project Feasibility Study, page-263
-
- There are more pages in this discussion • 202 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add QPM (ASX) to my watchlist
|
|||||
Last
3.4¢ |
Change
0.001(3.03%) |
Mkt cap ! $85.70M |
Open | High | Low | Value | Volume |
3.5¢ | 3.6¢ | 3.3¢ | $255.5K | 7.404M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 749999 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 675468 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 749999 | 0.034 |
11 | 1375659 | 0.033 |
12 | 3292967 | 0.032 |
7 | 1598958 | 0.031 |
10 | 792998 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 675468 | 3 |
0.036 | 790884 | 8 |
0.037 | 910393 | 4 |
0.038 | 598000 | 3 |
0.039 | 500000 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
QPM (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online